Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study on the Effectiveness of Choline Alfoscerate in Subthreshold Depression of the Elderly
2021-003437-10Phase 4Active
- Sponsor
- ASST Lodi
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of choline alfoscerate in major depressive disorder (MDD), sponsored by ASST Lodi. Primary endpoint: Change in HAMD-17 score from baseline to final visit. Started Oct 2021; status: active.
02
Drugs
choline alfoscerate
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2021-003437-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-003437-10.